PGI23 TREATMENT COST ANALYSIS FOR PATIENTS IN THE UNITED STATES WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS WHO HAVE AN INADEQUATE RESPONSE OR WHO ARE INTOLERANT TO TNF BLOCKERS
Abstract
Authors
A. Sardesai S. Milev P. Quon J. Bourret K. Peeples-Lamirande L. Salese J.C. Cappelleri P.P. Sharma